2018-10-15 12:05:00 CEST

2018-10-15 12:05:50 CEST


REGULATED INFORMATION

English Finnish
Silmäasema Oyj - Major shareholder announcements

Silmäasema Oyj: Notification according to chapter 9, section 5 of the Securities Market Act: Coronaria's ownership in Silmäasema has increased above 15 percent


Silmäasema Oyj: Notification according to chapter 9, section 5 of the Securities
Market Act: Coronaria's ownership in Silmäasema has increased above 15 percent

Silmäasema Oyj
Stock Exchange Release
15 October 2018 at 13:05 p.m. EEST



Silmäasema Oyj has on 15 October 2018 received a notification under Chapter 9,
Section 5 of the Securities Markets Act, according to which the holding of
Coronaria Oy in Silmäasema's shares and votes has exceeded 15 percent on 12
October 2018.

According to the notification, Coronaria's holding in Silmäasema's shares and
votes is 19.72 percent.

Silmäasema Oyj has one series of shares in which each share carries one vote.
The aggregate number of shares is 14,248,805.

Total positions of Coronaria subject to the notification:

+------------------+------------+-----------------+------------+---------------+
|                  |% shares and|% of shares and  |Total of    |Total number of|
|                  |voting      |voting rights    |both in %   |shares and     |
|                  |rights (A)  |through financial|(A+B)       |voting rights  |
|                  |            |instruments (B)  |            |of issuer      |
+------------------+------------+-----------------+------------+---------------+
|Resulting         |            |                 |            |               |
|situation of the  |            |                 |            |               |
|date on which the |19.72%      |                 |19.72%      |     14,248,805|
|threshold was     |            |                 |            |               |
|crossed of reached|            |                 |            |               |
+------------------+------------+-----------------+------------+---------------+
|Position of       |            |                 |            |               |
|previous          |12.28%      |                 |12.28%      |     14,248,805|
|notification (if  |            |                 |            |               |
|applicable)       |            |                 |            |               |
+------------------+------------+-----------------+------------+---------------+


Notified details of the resulting situation on the date on which the threshold
was crossed:

A: Shares and voting rights:

+-------------------+------------------------------+---------------------------+
|Class/type of      |Number of shares and voting   |% of shares and voting     |
|shares ISIN code   |rights                        |rights                     |
+-------------------+---------------+--------------+------------+--------------+
|                   |Direct (SMA    |Indirect (SMA |Direct (SMA |Indirect (SMA |
|                   |9:5)           |9:6 and 9:7)  |9:5)        |9:6 and 9:7)  |
+-------------------+---------------+--------------+------------+--------------+
|FI4000243399       |2,809,642      |              |19.72%      |              |
+-------------------+---------------+--------------+------------+--------------+
|Subtotal A         |2,809,642      |              |19.72%      |              |
+-------------------+---------------+--------------+------------+--------------+






SILMÄASEMA OYJ

Anu Kankkunen, Interim CEO, CFO, tel. +358 50 669 69
Tuukka Hirvonen, Head of Communications and Investor Relations, tel.
+358 50 416 7700



Silmäasema is a Finnish company, which offers all products and services for
optical retail and eye healthcare nationwide. Silmäasema is the largest private
eye clinic provider offering eye surgeries and the second largest optical retail
chain in Finland. The Silmäasema chain has over 150 stores and 14 eye clinics in
Finland as well as ten stores in Estonia. The Silmäasema chain employs close to
1,000 eye healthcare professionals. Silmäasema's Group net sales were EUR 118.3
million in 2017 and adjusted EBITDA was EUR 11.8 million.




[]